APC-Targeted Vaccines Deliver Antigen Specific Immune Tolerance

Time: 2:30 pm
day: Custom Day Two

Details:

• Latest updates on the development of Nykode's APC-targeted tolerogenic vaccines

• Novel pre-clinical PoC and MoA data in autoimmune disease models using different APC-targeting vaccine approaches 

Speakers: